After the JWH133 intervention, the mice exhibited improvement in the aforementioned pathological examinations; moreover, reduced mRNA and protein levels of the relevant indicators of pulmonary fibrosis activation, such as Col-I, Col-III, and α-SMA, were observed. This evidence concerns the gene ACTA1 and pulmonary fibrosis.